Tandem Diabetes Care is headquartered in San Diego, US
Key People at Tandem Diabetes Care
Kim D. Blickenstaff
President , CEO & Board Of Director
John Cajigas
CFO
Jim Leal
VP, Operations
Bob Anacone
EVP and Chief Commercial Officer
Susan Morrison
VP, HR, Corporate & Investor Relations
Tandem Diabetes Care Office Locations
Tandem Diabetes Care has an office in San Diego
San Diego, US (HQ)
11045 Roselle St
Tandem Diabetes Care Data and Metrics
Tandem Diabetes Care Financial Metrics
Tandem Diabetes Care's revenue was reported to be $84.2 m in FY, 2016 which is a 16% increase from the previous period.
Numbers are in $, USD
Revenue (FY, 2016) | 84.2 m |
Revenue growth (FY, 2015 - FY, 2016), % | 16% |
Gross profit (FY, 2016) | 23.6 m |
Gross profit margin (FY, 2016), % | 28% |
Net income (FY, 2016) | (83.4 m) |
EBIT (FY, 2016) | (78.1 m) |
Market capitalization (31-May-2017) | 39.6 m |
Closing share price (31-May-2017) | 0.8 |
Cash (31-Dec-2016) | 44.7 m |
EV | 73.9 m |
Tandem Diabetes Care's current market capitalization is $39.6 m.
| Numbers are in $, USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Revenue | 49.7 m | 72.9 m | 84.2 m |
Revenue growth, % | 47% | 16% | |
Cost of goods sold | 34.5 m | 46.3 m | 60.7 m |
Gross profit | 15.2 m | 26.6 m | 23.6 m |
Gross profit Margin, % | 31% | 36% | 28% |
Operating expense total | 90.9 m | 95.6 m | 101.6 m |
EBIT | (75.7 m) | (69 m) | (78.1 m) |
EBIT margin, % | (152%) | (95%) | (93%) |
Net Income | (79.5 m) | (72.4 m) | (83.4 m) |
| Numbers are in $, USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Cash | 31.2 m | 43.1 m | 44.7 m |
Accounts Receivable | 7.7 m | 14.1 m | 11.2 m |
Inventories | 11.9 m | 17.5 m | 21.2 m |
Current Assets | 90.8 m | 107 m | 92.1 m |
PP&E | 12.6 m | 15.5 m | 18.4 m |
Total Assets | 106.5 m | 125.1 m | 112.4 m |
Accounts Payable | 1.9 m | 5.2 m | 7.5 m |
Total Debt | 29.4 m | 29.3 m | 79 m |
Current Liabilities | 18.1 m | 26.5 m | 31.5 m |
Non-Current Liabilities | 33.8 m | 34.7 m | 86.8 m |
Total Liabilities | 51.9 m | 61.3 m | 118.3 m |
Additional Paid-in Capital | 303.3 m | 384.6 m | 398.6 m |
Retained Earnings | (248.7 m) | (321.1 m) | (404.6 m) |
Total Equity | 33.8 m | 63.5 m | (5.9 m) |
Debt to Equity Ratio | 0.9 x | 0.5 x | -13.3 x |
Debt to Assets Ratio | 0.3 x | 0.2 x | 0.7 x |
Financial Leverage | 3.2 x | 2 x | -19 x |
| Numbers are in $, USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Net Income | (79.5 m) | (72.4 m) | (83.4 m) |
Depreciation and Amortization | 4.4 m | 4.8 m | 5.5 m |
Accounts Receivable | (2.5 m) | (6.5 m) | 2.3 m |
Inventories | (1.8 m) | (6.1 m) | (6.9 m) |
Accounts Payable | (1.2 m) | 3.4 m | 3.2 m |
Cash From Operating Activities | (61.4 m) | (58.8 m) | (61.2 m) |
Purchases of PP&E | (4.4 m) | (5.8 m) | (8.9 m) |
Cash From Investing Activities | (35.5 m) | 2.4 m | 10.4 m |
Short-term Borrowings | (30 m) | ||
Cash From Financing Activities | 3.6 m | 68.3 m | 52.3 m |
Interest Paid | 3.4 m | 3.3 m | 4.4 m |
Income Taxes Paid | 71 k | 9 k | 23 k |
| Y, 2016 | |
|---|---|
EV/EBIT | -0.9 x |
EV/CFO | -1.2 x |
Debt/Equity | -13.3 x |
Debt/Assets | 0.7 x |
Financial Leverage | -19 x |
Tandem Diabetes Care Operating Metrics
Tandem Diabetes Care's Devices Sold was reported to be 50 k in FY, 2016
- Source: SEC Filings
